Shane E. Holloway

1.1k total citations
14 papers, 921 citations indexed

About

Shane E. Holloway is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Shane E. Holloway has authored 14 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Shane E. Holloway's work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Shane E. Holloway is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Shane E. Holloway collaborates with scholars based in United States and Spain. Shane E. Holloway's co-authors include Rolf A. Brekken, Jason B. Fleming, Adam W. Beck, David A. Geller, Carlton C. Barnett, M. Natalie Davis, Jennifer L. Steel, J. Wallis Marsh, T. Clark Gamblin and Andrew F. Miller and has published in prestigious journals such as Cancer, Cancer Research and International Journal of Cancer.

In The Last Decade

Shane E. Holloway

14 papers receiving 901 citations

Peers

Shane E. Holloway

ONCOL

HEPAT

SURGE

IMMUN

Lutz Peter Mueller Germany

Paola Bonetti Italy

Andrés Rojas United States

Mingxia Shi China

Ming‐Han Chen Taiwan

Zhendong Chen China

Yuchen Ye China

Dongchang Zhao United States

J. Eduardo Pérez Spain

Xuan Zheng China

Lutz Peter Mueller Germany

Shane E. Holloway

342 ×1.0

258 ×0.9

ONCOL

188 ×0.9

HEPAT

332 ×1.9

SURGE

52 ×0.3

IMMUN

Citations per year, relative to Shane E. Holloway Shane E. Holloway (= 1×) peers Lutz Peter Mueller

Countries citing papers authored by Shane E. Holloway

Since Specialization

Citations

This map shows the geographic impact of Shane E. Holloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane E. Holloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane E. Holloway more than expected).

Fields of papers citing papers by Shane E. Holloway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane E. Holloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane E. Holloway. The network helps show where Shane E. Holloway may publish in the future.

Co-authorship network of co-authors of Shane E. Holloway

This figure shows the co-authorship network connecting the top 25 collaborators of Shane E. Holloway. A scholar is included among the top collaborators of Shane E. Holloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane E. Holloway. Shane E. Holloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Barnett, Carlton C., Adam W. Beck, Shane E. Holloway, et al.. (2010). Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice. Cancer. 116(16). 3862–3874. 17 indexed citations

Davies, Daniel K., Steven E. Stock, Shane E. Holloway, & Michael L. Wehmeyer. (2010). Evaluating a GPS-Based Transportation Device to Support Independent Bus Travel by People With Intellectual Disability. Intellectual and developmental disabilities. 48(6). 454–463. 85 indexed citations

Dineen, Seán, Kristi D. Lynn, Shane E. Holloway, et al.. (2008). Vascular Endothelial Growth Factor Receptor 2 Mediates Macrophage Infiltration into Orthotopic Pancreatic Tumors in Mice. Cancer Research. 68(11). 4340–4346. 161 indexed citations

Cho, Sung W., J. Wallis Marsh, Jennifer L. Steel, et al.. (2008). Surgical Management of Hepatocellular Adenoma: Take It or Leave It?. Annals of Surgical Oncology. 15(10). 2795–2803. 103 indexed citations

Marsh, J. Wallis, Paulo Fontes, Nikhil B. Amesur, et al.. (2008). Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation. Annals of Surgical Oncology. 15(11). 3169–3177. 107 indexed citations

Gamblin, Clark T., et al.. (2008). Laparoscopic Resection of Benign Hepatic Cysts: A New Standard. Journal of the American College of Surgeons. 207(5). 731–736. 53 indexed citations

Arnold, Shanna A., E. Mira, Sabeeha Muneer, et al.. (2008). Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC. Experimental Biology and Medicine. 233(7). 860–873. 60 indexed citations

Holloway, Shane E., Adam W. Beck, Latha Shivakumar, et al.. (2006). Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts. Annals of Surgical Oncology. 13(8). 1145–1155. 26 indexed citations

Holloway, Shane E., Adam W. Beck, Luc Girard, et al.. (2005). Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. Journal of the American College of Surgeons. 200(3). 371–377. 68 indexed citations

10.

Beck, Adam W., Troy A. Luster, Andrew F. Miller, et al.. (2005). Combination of a monoclonal anti‐phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice. International Journal of Cancer. 118(10). 2639–2643. 65 indexed citations

11.

Fleming, Jason B., et al.. (2005). Molecular Consequences of Silencing Mutant K-ras in Pancreatic Cancer Cells: Justification for K-ras–Directed Therapy. Molecular Cancer Research. 3(7). 413–423. 150 indexed citations

12.

Beck, Andy, et al.. (2004). Genetic expression in pancreatic adenocarcinoma cells predicts metastatic potential and response to oxidative stress. Journal of Surgical Research. 121(2). 309–309. 1 indexed citations

13.

Holloway, Shane E., et al.. (2003). A Clinically Relevant Model of Human Pancreatic Adenocarcinoma Identifies Patterns of Metastasis Associated with Alterations of the TGF-β/Smad4 Signaling Pathway. International Journal of Gastrointestinal Cancer. 33(1). 61–70. 6 indexed citations

14.

Holloway, Shane E., George A. Sarosi, Lawrence Kim, et al.. (2002). Health-Related Quality of Life and Postoperative Length of Stay for Patients with Colorectal Cancer. Journal of Surgical Research. 108(2). 273–278. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact